The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Timing of testing for K-ras mutational status in metastatic colorectal cancer (mCRC).
Mitra Corral
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Michelle Sotak
Employment or Leadership Position - OptumInsight
Benjamin Chastek
Employment or Leadership Position - OptumInsight
John R. Penrod
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Jessica Cairns
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
David A. Williams
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb